Lexaria Bioscience Corp. — Regulatory Filings 2012

Jun 27, 2012

CORRESP 1 filename1.htm Lexaria Corp.: Correspondence - Filed by newsfilecorp.com $$/page=

LEXARIA CORP. Suite 950, 1130 West Pender Street Vancouver, BC, V6E 4A4

June 27, 2012

VIA EDGAR

United States Securities and Exchange Commission 100 F Street North East Mail Stop 20549-0407 Washington, DC 20549

Dear Sirs:

Re: Lexaria Corp. (the "Company")

In connection with the Company's Form S-1 Registration Statement (file no. 333-180125), the Company hereby requests acceleration of the effective date of the Registration Statement to 9:30 a.m. (EST) Monday, July 2, 2012 or as soon thereafter as possible, in accordance with Rule 461(a) of Regulation C.

We acknowledge that

| (i) | should the Securities and Exchange Commission (the " Commission ") or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing, | | --- | --- | | (ii) | the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing, and | | (iii) | the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |

We trust you will find the foregoing to be in order. Please do not hesitate to contact the undersigned should you have any questions in this regard.

Yours truly,
LEXARIA CORP.
	/s/ Christopher
Bunka
Per:	Christopher Bunka
	President